Enhancement of immune responses to an HIV gp120 DNA vaccine by fusion to TNF alpha cDNA

Vaccine

Volumn 24, Issue 16, 2006, Pages 3298-3308

  Nimal, Sonali ^a   Heath, Andrew W ^a   Thomas, Mark S ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Adjuvant; Cytokine; DNA; gp120; HIV; TNF; Vaccine

Indexed keywords

DNA VACCINE; GAMMA INTERFERON; GLYCOPROTEIN GP 120; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; PLASMID DNA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ADJUVANT THERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOGENICITY; IN VITRO STUDY; INFECTION PREVENTION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE;

ADJUVANTS, IMMUNOLOGIC; AIDS VACCINES; ANIMALS; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HIV ANTIBODIES; HIV ENVELOPE PROTEIN GP120; HIV-1; IMMUNOGLOBULIN G; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; RECOMBINANT FUSION PROTEINS; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA; VACCINES, DNA;

EID: 33645050385     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.01.020     Document Type: Article

References (33)

1. J.J. Donnelly, J.B. Ulmer, and M.A. Liu DNA vaccines Dev Biol Stand 95 1998 43 53
2. H.O. Alpar, I. Papanicolaou, and V.W. Bramwell Strategies for DNA vaccine delivery Expert Opin Drug Deliv 2 2005 829 842
3. J.J. Donnelly, B. Wahren, and M.A. Liu DNA vaccines: progress and challenges J Immunol 175 2005 633 639
4. M.A. Kutzler, and D.B. Weiner Developing DNA vaccines that call to dendritic cells J Clin Invest 114 2004 1334 1342
5. M.J. Estcourt, A.J. McMichael, and T. Hanke DNA vaccines against human immunodeficiency virus type 1 Immunol Rev 199 2004 144 155
6. J.F. Bower, K.L. Sanders, and T.M. Ross C3d enhances immune responses using low doses of DNA expressing the HIV-1 envelope from codon-optimized gene sequences Curr HIV Res 3 2005 191 198
7. T.R. Jones, D.L. Narum, A.S. Gozalo, J. Aguiar, S.R. Fuhrmann, and S. Kumar Protection of Aotus monkeys by Plasmodium falciparum EBA-175 region II DNA prime-protein boost immunization regime J Infect Dis 183 2001 303 312
8. J. Schneider, S.C. Gilbert, T.J. Blanchard, T. Hanke, K.J. Robson, and C.M. Hannan Enhanced immunogenicity for CD8 + T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara Nat Med 4 1998 397 402
9. S.J. Kent, A. Zhao, S.J. Best, J.D. Chandler, D.B. Boyle, and I.A. Ramshaw Enhanced T-cell immunogenicity and protective efficacy of a human immunodeficiency virus type 1 vaccine regimen consisting of consecutive priming with DNA and boosting with recombinant fowlpox virus J. Virol 72 1998 180 188
10. H.L. Robinson, D.C. Montefiori, R.P. Johnson, K.H. Manson, M.L. Kalish, and J.D. Lifson Neutralising antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations Nat Med 5 1999 526 534
11. J.H.L. Playfair, and J.B. De Souza Recombinant gamma-interferon is a potent adjuvant for a malaria vaccine in mice Clin Exp Immunol 67 1987 5 10
12. A.W. Heath, M. Devey, I. Brown, C.E. Richards, and J.H.L. Playfair Interferon gamma as an adjuvant in immunocompromised mice Immunology 67 1989 520 524
13. A.W. Heath, and J.H.L. Playfair Conjugation of interferon gamma to antigen enhances its adjuvanticity Immunology 71 1990 454 456
14. A.L. McCormick, M.S. Thomas, and A.W. Heath Immunization with interferon gamma-gp120 fusion protein induces enhanced immune responses to human immunodeficiency virus gp120 J Infect Dis 184 2001 1423 1430
15. A.W. Heath, and J.H.L. Playfair Cytokines as immunological adjuvants Vaccine 10 1992 427 443
16. S. Nimal, A.L. McCormick, M. Thomas, and A.W. Heath An interferon gamma gp120 fusion delivered as a DNA vaccine induces enhanced priming Vaccine 23 2005 3984 3990
17. J. Vilcek, and T.H. Lee Tumour necrosis factor. New insights into the molecular mechanisms of its multiple actions J Biol Chem 266 1991 7313 7316
18. W. Fiers Tumor necrosis factor. Characterisation at the molecular, cellular and in vivo level FEBS Lett 285 1991 199 212
19. K.J. Tracey, and A. Cerami Tumor necrosis factor: a pleiotropic cytokine and therapeutic target Annu Rev Med 45 1994 491 503
20. J.J. Kim, N.N. Trivedi, L.K. Nottingham, L. Morrison, A. Tsai, and Y. Hu Modulation of amplitude and direction of in vivo immune responses by co-administration of cytokine gene expression cassettes with DNA immunogens Eur J Immunol 28 1998 1089 1103
21. R. Pujol-Borrell, I. Todd, M. Doshi, G.F. Botazzo, R. Sutton, and D. Gray HLA class II induction in human islet cells by interferon-gamma plus tumor necrosis factor or lymphotoxin Nature 326 1987 304 306
22. J.D. Ahlers, N. Dunlop, D.W. Alling, P.L. Nara, and J.A. Berzofsky Cytokine-in-adjuvant steering of the immune response phenotype to HIV-1 vaccine constructs: granulocyte-macrophage colony-stimulating factor and TNF-alpha synergise with IL-12 to enhance induction of cytotoxic T lymphocytes J Immunol 158 1997 3947 3958
23. R.R. Amara, F. Villinger, J.D. Altman, S.L. Lydy, S.P. O'Neil, and S.I. Staprans Control of a mucosal challenge and prevention of AIDS by multiprotein DNA/MVA vaccine Science 292 2001 69 74
24. J.B. Ulmer, C.M. DeWitt, M. Chastain, A. Firedman, J.J. Donelly, and W.L. McClements Enhancement of DNA vaccine potency using conventional aluminum phosphate adjuvants Vaccine 18 1999 18 28
25. S. Wang, X. Liu, K. Fisher, J.G. Smith, F. Chen, and T.W. Tobery Enhanced type I immune response to a hepatitis B DNA vaccine by formulation with calcium or aluminum phosphate Vaccine 18 2000 1227 1235
26. D.R. Spriggs, S. Deutsh, and D.W. Kufe Genomic structure, induction, and production of TNF-alpha Immunol Ser 56 1992 3 34
27. M. Kriegler, C. Perez, K. DeFay, I. Albert, and S.D. Lu A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein; ramifications for the complex physiology of TNF Cell 853 1998 45 53
28. R.A. Black, C.T. Rauch, C.J. Kozlosky, J.J. Peschon, J.L. Slack, and M.F. Wolfson A metalloproteinase disintegrin that releases tumor necrosis factor-α from cells Nature 385 1997 729 773
29. M.L. Moss, S.L. Jin, M.E. Milla, D.M. Bickett, W. Burkhart, and H.L. Carter Cloning of a disintegrin mellanoproteinase that processes precursor tumor necrosis factor-α Nature 385 1997 733 736
30. C. Perez, I. Albert, K. DeFay, N. Zachariades, L. Gooding, and M. Kriegler A nonsecretable cell surface mutant of tumor necrosis factor kills by cell to cell contact Cell 63 1990 251 258
31. The Global AIDS vaccine enterprise. Scientific strategic plan. Co-ordinating committee of the Global HIV/AIDS vaccine enterprise. Plos Medicine 2005; e25.
32. H. Cui, X.H. Chang, B. Liu, J. Feng, Y. Li, and X. Ye The anti-tumor immune responses induced by a fusion protein of ovarian carcinoma anti-idiotypic antibody 6B11ScFv and murine GM-CSF in BALB/c mice Int J Gynecol Cancer 14 2004 234 241
33. J. Wales, M. Baird, N. Davies, and G. Buchan Fusion of interleukin-2 to subunit antigens increase their antigenicity in vitro due to an interleukin-2 receptor beta-mediated antigen uptake mechanism Scand J Immunol 58 2003 367 373